Weiss Multi-Strategy Advisers’s ResMed RMD Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-5,000	Closed	-$324K	–	502
2016 Q3	$324K	Buy	+5,000	New	+$333K	0.02%	374

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Weiss Multi-Strategy Advisers's RMD Position: Q3 2023 in Review

Weiss Multi-Strategy Advisers sold out of ResMed (RMD) in Q3 2023, closing a stake of 16,995 shares — an estimated $3.71M sold.

Weiss Multi-Strategy Advisers first reported a position in RMD in Q2 2013 and held it in 6 quarters. The position peaked at $3.71M in Q2 2023. 657 funds tracked by Wall St. Rank hold RMD as of Q3 2023.

Weiss Multi-Strategy Advisers reported no remaining ResMed position as of Q3 2023 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 16,995 ResMed shares in Q3 2023, an estimated $3.71M.
Weiss Multi-Strategy Advisers first reported a position in ResMed in Q2 2013 and held it in 6 quarters.
Weiss Multi-Strategy Advisers's ResMed position peaked at $3.71M in Q2 2023.
657 funds tracked by Wall St. Rank held ResMed as of Q3 2023.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2023, filed 14 Nov 2023.